12.10.2017 | Ajankohtaista
The University of Oslo is Norway’s oldest and highest ranked educational and research institution, with 28 000 students and 7000 employees. With its broad range of academic disciplines and internationally recognised research communities, UiO is an important contributor to society.
Centre for Molecular Medicine Norway (NCMM) was established in 2008 and is the Norwegian node in the Nordic EMBL Partnership for Molecular Medicine. NCMM is a joint venture between the University of Oslo, Health Region South-East and the Research Council of Norway. From 2017 NCMM is merged with the Biotechnology Centre of Oslo and now has altogether 11 research groups. The overall objective of NCMM is to conduct cutting edge research in molecular medicine and biotechnology as well as facilitate translation of discoveries in basic medical research into clinical practice.
NCMM is now seeking new outstanding international candidates for a Group Leader position with start-up package in Systems medicine
NCMM Biotechnology expects to hire one new principal investigator through this call, and we particularly encourage international applicants. The successful candidate is expected to initiate a new independent research program with a clear relevance to molecular medicine and disease mechanisms integrating computational biology approaches with experimental science. The research should consolidate existing research within the Centre (see web-site). NCMM plans for all group leaders at NCMM Biotechnology to have adjunct appointments at other University Departments. Furthermore, we expect multi-disciplinary research collaborations with other NCMM research groups and NCMM Associate Investigators, with the internationally recognized biomedical and medical research environment in Oslo as well as with other top Norwegian scientists and within the Nordic EMBL Partnership.
12.10.2017 | Ajankohtaista
The University of Oslo is Norway’s oldest and highest ranked educational and research institution, with 28 000 students and 7000 employees. With its broad range of academic disciplines and internationally recognised research communities, UiO is an important contributor to society.
Centre for Molecular Medicine Norway (NCMM) was established in 2008 and is the Norwegian node in the Nordic EMBL Partnership for Molecular Medicine. NCMM is a joint venture between the University of Oslo, Health Region South-East and the Research Council of Norway. From 2017 NCMM is merged with the Biotechnology Centre of Oslo and now has altogether 11 research groups. The overall objective of NCMM is to conduct cutting edge research in molecular medicine and biotechnology as well as facilitate translation of discoveries in basic medical research into clinical practice.
NCMM is now seeking new outstanding international candidates for a Group Leader position with start-up package in Precision Medicine
NCMM Translational Research expects to hire one new principal investigator through this call, and we particularly encourage international applicants. The successful candidate is expected to initiate a new independent research program with a clear relevance to molecular medicine and disease mechanisms with approaches to individualized diagnostics and therapy. The research should consolidate existing research within the Centre (see web-site). NCMM plans for all group leaders at NCMM Translational Research to have adjunct appointments in university hospital departments to facilitate translation and clinical collaboration. Furthermore, we expect multi-disciplinary research collaborations with other NCMM research groups and NCMM Associate Investigators, with the internationally recognized biomedical and medical research environment in Oslo as well as with other top Norwegian scientists and within the Nordic EMBL Partnership.
More information and application at www.jobbnorge.no/ledige-stillinger/stilling/141940/group-leader-position-with-start-up-package-in-precision-medicine
12.10.2017 | Ajankohtaista
Senior Field Application Scientist (m/f) – QIAGEN, Hilden, Nordrhein-Westfalen, Deutschland
Job description
QIAGEN is one of the world’s leading biotechnology companies. With our sample to insight solutions that unlock valuable molecular information from biological samples, QIAGEN helps to improve healthcare and safeguard our societies, enables the development of new medicines and paves the way for scientific breakthroughs.
Join the revolution – and see how you can make a difference.Senior Field Application Scientist (m/f)
Job ID #: 7726
Functional Area: Sales
Employment Type: Regular Full-Time
Duration: unlimited
Location: Hilden (near Duesseldorf), Germany
Position Description
This is a unique opportunity to join the QIAGEN Bioinformatics team responsible for commercialising QIAGEN’s bioinformatics products. The Field Application Scientist (FAS) position allows you to interact with a wide range of researchers across different scientific disciplines to promote software applications and services that provide superior NGS and Genomic data analysis and biological interpretation, and to provide product and scientific advice to key accounts.The FAS is responsible for working closely with key accounts and early access customers, delivering scientific software demonstrations for groups of various sizes, conduct software evaluations and product training, and other activities to help potential customers understand the value of QIAGEN’s bioinformatics applications and services.The scientist will work strategically with Sales as well as with Marketing, Customer Support, and the extended EMEA and global Field Application Scientist teams to support customers in the pharmaceutical, biotech, governmental, and academic sectors.This is a field-based role, ideally based in Southern Germany or the DACH region. Candidates should be prepared to experience periods of up to 60% travel, although average annual levels will be less.
– Engage in scientific discussions with customers and cultivate relationships.- Train and support new customers.
– Analyze and interpret large molecular datasets such as DNA-Seq, RNA-Seq, microarray and proteomics data for clinical and basic research purposes.
– Be the technical expert on QIAGEN Bioinformatics Applications and provide scientific presentations, compelling pre-sales product demonstrations, and scientific workshops to showcase the value and effectiveness of QIAGEN Bioinformatics.
Position Requirements
– Ph.D. or equivalent experience in bioinformatics, molecular biology or genetics-related fields of study stressing data analysis and biological interpretation of Next Generation Sequencing data, ideally using the CLC Genomics or Biomedical Genomics Workbench.
– Demonstrated excellent written, presentation, and verbal skills including strong public speaking experience.
– Excellent interpersonal and relationship-building skills.- Aptitude for understanding, communicating, and training scientific concepts, applications and methods.
– Demonstrated exceptional analytical and problem solving skills.
Personal Requirements
– Ability to travel between 30-60% of the time, including overnight stays.
– Ability to multitask a variety of assignments and proven ability to meet strict deadlines.
– Ability to be flexible and creative, and work in a fast-paced, high-growth environment.
– Fast, self-starter with the ability to handle and manage multiple tasks in a result-orientated commercial environment.
– Excellent project and network management skills and strong organizational skills.
– Experience as a remote, field-based employee desirable.
– Fluency in German and English language.If this interdisciplinary challenge appeals to you, you can expect a highly motivated team that is looking forward to your support! Please apply online, quoting the reference number, with your complete application documents as well as your earliest starting date and salary expectations.
We look forward to hearing from you!
Technical Application Scientist, Next Generation Sequencing – GENEWIZ, Cologne Area, Germany
Job description
Want to be part of a company whose goal is to be the best in the world and the best for the world?
Apply today!
GENEWIZ is seeking a Technical Application Scientist to join our Next Generation Sequencing team.
Title: Technical Application Scientist
Location: Cologne, Germany
Responsibilities:
- Communicate project requirements, status, and deadlines with customers and internal teams
- Design and execute customer care workflows
- Promote NGS business by visiting prospective and current customers, attending vendor shows and conferences, and providing technical webinars and poster presentations
- Assist Marketing with the development of GENEWIZ positioning, communication strategies, web page design, and promotions
- Train Sales, Marketing, and PM on NGS products and services
- Work with PM and NGS scientists to provide customers with pre-sale consultation and after-sale technical support
Qualifications:
- MS Degree in Biological Sciences required
- PhD in Biological Sciences preferred
- Strong knowledge of Next Generation Sequencing, both wet and dry lab, required
- 2+ years of hands-on Next Generation Sequencing experience, both wet and dry lab, preferred
- Project management experience preferred
- Ability to multitask and meet deadlines in a fast-paced, customer-oriented environment
- Excellent interpersonal skills; excellent verbal and written communication skills
- Willing and able to travel overnight (up to 25%)
11.10.2017 | Ajankohtaista
The Institute for Molecular Medicine Finland (FIMM) is an international research institute focusing on human genomics and personalised medicine at the University of Helsinki. In the beginning of 2017 FIMM joined the University of Helsinki’s new life science research centre, Helsinki Institute of Life Science HiLIFE, as an operational unit. FIMM integrates molecular medicine research, technology centre and biobanking infrastructures under one roof, promoting translational research in grand challenge projects, specifically, the impact of genome information from the Finnish population in personalised health and medicine, individualised cancer medicine, and digital molecular medicine. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community.
Research Coordinator for High Throughput Screening Operations
The High Throughput Biomedicine (HTB) unit of the FIMM Technology Centre performs high throughput bioassays, mainly cell-based drug screening and RNAi experiments. The unit supports research at University of Helsinki and functions as a national and international infrastructure platform mainly for academic researchers. We currently have an opening for a Research Coordinator for project management and coordination. The primary activities of the position include, but are not limited to:
– Project management and coordination
– Method and protocol development (especially in 3D tumor models)
– High throughput screening
– Administration of the HTB unit
The Research Coordinator will work independently as well as closely with HTB researchers and staff. The specific tasks include management of academic/company collaborations, in vitro disease modeling, microscopy, administration of unit finances and academic writing of applications and reports, high throughput screening, protocol development and data management.
Qualification and experience:
Candidates should have PhD degree in biotechnology, biology, biochemistry, engineering, or a related discipline including proven experience with at least: project management and coordination, supervision of personnel, drug sensitivity testing, handling of clinical samples, cell culture, biochemical, molecular, or cellular techniques, assay development, high content microscopy, flow cytometry, laboratory automation, robotics, and high-throughput screening. The successful candidate is expected to have excellent problem solving, organisational, and analytical skills, and is able to work systematically. In addition, the candidate should be fluent in English, have good interpersonal and communication skills, a service-minded attitude, and be able to work independently as well as within a team.
11.10.2017 | Ajankohtaista
The Institute for Molecular Medicine Finland (FIMM) is an international research institute focusing on human genomics and personalised medicine at the University of Helsinki. In the beginning of 2017 FIMM joined the University of Helsinki’s new life science research centre, Helsinki Institute of Life Science HiLIFE, as an operational unit. FIMM integrates molecular medicine research, technology centre and biobanking infrastructures under one roof, promoting translational research in grand challenge projects, specifically, the impact of genome information from the Finnish population in personalised health and medicine, individualised cancer medicine, and digital molecular medicine. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community.
FIMM Technology Centre is currently seeking for a senior researcher to act as Unit Head for the High Throughput Biomedicine Unit
The High Throughput Biomedicine (HTB) unit of the FIMM Technology Centre performs high throughput bioassays, cell-based drug screening and RNAi experiments. The unit supports research at the University of Helsinki and functions as a national and international infrastructure platform mainly for academic researchers. We are currently looking for a Unit Head.
The primary activities of the position include, but are not limited to:
– Networking and acquiring new projects
– Developing the unit’s strategy together with the director of the FIMM TC, unit staff, and unit’s user advisory panel
– Establishing and participating national and international collaborations
– Applying for national and international grants, grant reporting
– Responsibility of unit finances
Qualification and experience:
Qualification requirements include an MD/PhD, PhD or equivalent degree, postdoctoral training, project management, method development, and a strong publication record in the field. International mobility, such as training in high-quality institutions and universities globally will be valued as wells as a wide personal network in the research area. We expect that the Unit Head will engage in multidisciplinary research collaborations with other FIMM research groups, and with the life science community in Helsinki. Translational focus towards diagnostics and personalized medicine is valued along with the possibility of providing additional and novel contributions to existing FIMM and Meilahti campus research groups. Candidates should have a strong background in research and high throughput screening and proven experience with at least: industrial collaborations, project management and coordination, and supervision of personnel. Prior experience with drug sensitivity testing as well as industry/company experience, will be valued. The successful candidate is expected to have excellent problem solving, organizational, and analytical skills, and is able to work systematically. In addition, the candidate should be fluent in English, have good interpersonal and communication skills, and modern leadership skills.
9.10.2017 | Ajankohtaista
PhD student position in epithelial cancer cell biology, University of Oulu, Finland
2.10.2017 | Ajankohtaista
AbbVie on maailmanlaajuinen, tutkimuslähtöinen biolääkealan yhtiö, joka aloitti toimintansa vuonna 2013 eriydyttyään Abbottista. AbbViessä yhdistyvät bioteknologia-alan yrityksen fokus sekä pitkään toimineen johtavan lääkealan yrityksen asiantuntemus. Yhtiön missiona on kehittää ja markkinoida kehittyneitä hoitoja hankaliin ja vakaviin sairauksiin asiantuntemuksensa, sitoutuneen henkilöstönsä ja innovaatiokykynsä avulla. Vuonna 2017 AbbVien henkilöstöön kuuluu noin 29 000 työntekijää ja yhtiö markkinoi lääkkeitä yli 175 maassa.
Suomessa AbbVie Oy on yksi Suomen parhaista työpaikoista. Organisaatiomme työllistää noin 85 ammattilaista Suomessa. Terapia-alueisiimme kuuluvat immunologia, onkologia, virologia ja neurologia. Työskentelemme matriisitiimeissä, joissa eri alueiden asiantuntijat toimivat yhteisen tavoitteen eteen. Haluamme, että kulttuurimme ja työilmapiirimme tukee työn iloa ja onnistumista sekä työn ja vapaa-ajan yhteensovittamista. Lue lisää meistä: www.abbvie.fi.
Nyt etsimme Lääketieteelliselle osastollemme uutta, valovoimaista asiantuntijaa nimikkeellä
Medical Advisor, Onkologia
Vastuullasi ovat toimintaamme liittyvät tieteelliset projektit ja koulutushankkeet. Olet tiiviisti yhteydessä asiakkaisiimme ja toimit itsenäisesti asiakkaidemme parissa osan työajastasi. Vastaat lääketieteellisestä työstä tuotteiden lanseerauksessa (mm. valmisteisiin liittyvät diagnostiset markkerit) ja rakennat kontakteja kyseisen terapia-alueiden asiantuntijoihin Suomessa. Varmistat pysyväsi alan tuoreimman tiedon tasalla seuraamalla tieteellisiä julkaisuja sekä osallistumalla kongresseihin. Jaat tietoa ja koulutat sekä sisäisiä että ulkoisia sidosryhmiä tuoreesta tutkimustiedosta vastuualueellasi. Työskentelet tiiviisti myynti- ja markkinointiorganisaatiomme kanssa sekä kollegojesi kanssa lääketieteellisessä tiimissä. Raportoit onkologian terapia-alueen Medical Managerille.
Tehtävä edellyttää lääketieteellistä, luonnontieteellistä tai muuta soveltuvaa ylempää korkeakoulututkintoa sekä vahvaa tieteellistä orientaatiota. Arvostamme aiempaa kokemusta akateemisesta tutkimusympäristöstä (esim. tohtorikoulutus) tai lääketeollisuuden parista. Taustaltasi voit olla esimerkiksi lääkäri, proviisori tai biotieteiden asiantuntija, tietämys onkologian alalta ja spesifisemmin keuhko- ja/tai aivosyövistä ovat eduksi. Itsenäisen ja ennakkoluulottoman työskentelyn ohella tehtävän menestyksekäs hoitaminen edellyttää vahvoja vuorovaikutus- ja tiimityöskentelytaitoja sekä valmiutta toimia matriisiorganisaatiossa. Lisäksi oleellisen tiedon hahmottaminen alan tutkimusartikkeleista ja kirjallisuudesta sekä tiedon selkeä ja ymmärrettävä kommunikointi mahdollistavat työssä menestymisen. Tarvitset työssä sujuvan suullisen ja kirjallisen kielitaidon sekä suomeksi että englanniksi. Olet kiinnostunut työskentelemään kaupallisessa ympäristössä ja vaikuttamaan potilaiden hoitoon yhteistyössä alan asiantuntijoiden kanssa.
Tarjoamme ainutlaatuisen näköalapaikan terveydenhuoltosektorilla osana menestyvää ja kasvavaa kansainvälistä yritystä sekä ympärillesi osaavan ja dynaamisen työyhteisön. Haluamme auttaa henkilöstöämme kehittymään niin, että he voivat hyödyntää potentiaalinsa parhaalla mahdollisella tavalla.
Kiinnostuitko? Lisätietoja tehtävästä antaa Medical Manager Hannu Mönkkönen puh. 050 5257 889, parhaiten tavoitettavissa ma-ti (4.-5.10. ja 11.-12.10.) klo 8:30-9:30 ja muina aikoina MPS-konsultti Nina Kalajoki puh. 020 746 9413.
29.9.2017 | Ajankohtaista
Taimen laboratory, at the Institute of Biomedicine, University of Turku, is looking for a highly motivated graduate student with a background in medicine, biology or biochemistry to join the research group on short notice. The deadline for this application is October 12, 2017 or until the position is filled.
Taimen Lab focuses on nuclear intermediate filaments called lamins and in particular, lamin mutations which cause inherited cardiac diseases such as dilated cardiomyopathy (DCM). So far, we have characterized the pathological effects of mutant lamin using molecular and cellular models. We now move into studying the disease in vivo. We have already generated a Drosophila strain expressing the mutant lamin and preliminary validated the phenotype on fruit fly. Additionally, we are in the process of acquiring a knock-in mouse strain carrying the lamin mutation. These models will allow us to study the molecular mechanisms of DCM in more detail and provide opportunities to test small molecular drugs to inhibit the effects of mutant lamin in vivo.
The recruited doctoral candidate will be characterizing the existing Drosophila model and the underlying molecular mechanisms. Furthermore, the candidate will participate in investigating the phenotype of the mouse model in the future. The work will include cell culture, molecular biology, histology, high resolution imaging and fruit fly and mouse handling. Any previous experience on aforementioned techniques is beneficial but not mandatory for the applicant.
The project is supported by the grant from the Academy of Finland (project funding 2017-2021), Sigrid Juselius Foundation (2017-2019) and Turku University hospital ERVA-funding.
Applications containing a motivation letter (max. 1 page), CV with list of publications (max. 2 pages) and contact information of max. 3 references should be sent as a single pdf to: pekka.taimen@utu.fi
Please further information please contact:
Pekka Taimen, MD, PhD, Adjunct professor in pathology Department of Pathology, University of Turku Kiinamyllynkatu 8-10, 20520 Turku
tel. 02-3131693
Related publications:
West G, Gullmets J, Virtanen L, Li SP, Keinänen A, Shimi T, Mauermann M, Heliö T, Kaartinen M, Ollila L, Kuusisto J, Eriksson JE, Goldman RD, Herrmann H, Taimen P (2016). Deleterious assembly of the lamin A/C mutant p.S143P causes ER stress in familial dilated cardiomyopathy. Journal of Cell Science 129:2732-43.
Alastalo TP, West G, Li SP, Keinänen A, Helenius M, Tyni T, Lapatto R, Turanlahti M, Heikkilä P, Kääriäinen H, Laakso M, Mauermann M, Herrmann H, Pihkala J, Taimen P (2015). LMNA Mutation c.917T>G (p.L306R) Leads to Deleterious Hyper-Assembly of Lamin A/C and Associates with Severe Right Ventricular Cardiomyopathy and Premature Aging. Human Mutation 36:694–703.
Taimen, P., Pfleghaar, K., Shimi, T., Möller, D., Ben-Harush, K., Erdos, M.R., Adam, S.A., Herrmann, H., Medalia, O., Collins, F.S., Goldman, A. and Goldman, R.D. (2009). A Progeria Mutation Reveals Functions for Lamin A in Nuclear Assembly, Architecture and Chromosome Organization. Proceedings of the National Academy of Sciences of the United States of America 106, 20788-20793.
Pekka Taimen, M.D., Ph.D.
Consulting Pathologist
Department of Pathology
University of Turku and Turku University Hospital Kiinamyllynkatu 10
20520 Turku
Finland
tel.(+358)-2-313 1693
mobile. (+358)-50-381 3468
27.9.2017 | Ajankohtaista
Area Sales Manager – BioNordika Oy – Helsinki Area, Finland
Job description
- You will use your in-depth knowledge and expert technical skills to acquire new customers from biotechnology companies, academic research institutions, and pharmaceutical companies, while simultaneously augmenting existing customer relationships
- In addition, you will go above and beyond by analyzing the market for new product opportunities.
- Your approach is consultative sales and you act as a knowledgeable resource for customers who have questions or product-related issues.
- you will be responsible for our full line of immunology and Cell Biology products throughout the designated territory
REQUIREMENTS
- In order to apply you should meet all or most of the following criteria:
- Degree qualified in a science related subject (Cell &Molecular Biology, Immunology) and further business qualifications can only be an advantage.
- Driving License
- Finnish and English language skills
- Strong entrepreneurial spirit.
- Excellent communication skills, result driven and creative.